80
Views
4
CrossRef citations to date
0
Altmetric
Review Article

Controversies in the use of endoscopic ultrasound in esophageal cancer staging

, PhD , MD &
Pages 133-144 | Received 07 Apr 2008, Published online: 08 Jul 2009

References

  • Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007; 8: 545–53
  • Rosch T. Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am 1995; 5: 537–47
  • Rice TW. Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am 2000; 10: 471–85
  • van Westreenen HL, Heeren PA, van Dullemen HM, van der Jagt EJ, Jager PL, Groen H, et al. Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations. J Gastrointest Surg 2005; 9: 54–61
  • Vazquez-Sequeiros E, Norton ID, Clain JE, Wang KK, Affi A, Allen M, et al. Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma. Gastrointest Endosc 2001; 53: 751–7
  • Pech O, May A, Rabenstein T, Ell C. Endoscopic resection of early oesophageal cancer. Gut 2007; 56: 1625–34
  • Westerterp M, van Westreenen HL, Reitsma JB, Hoekstra OS, Stoker J, Fockens P, et al. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy: systematic review. Radiology 2005; 236: 841–51
  • Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002; 95: 1434–43
  • Rice TW, Blackstone EH, Rybicki LA, Adelstein DJ, Murthy SC, DeCamp MM, et al. Refining esophageal cancer staging. J Thorac Cardiovasc Surg 2003; 125: 1103–13
  • Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono HA, et al. Developing an appropriate staging system for esophageal carcinoma. J Am Coll Surg 2005; 201: 884–90
  • Pfau PR, Ginsberg GG, Lew RJ, Brensinger CM, Kochman ML. EUS predictors of long-term survival in esophageal carcinoma. Gastrointest Endosc 2001; 53: 463–9
  • Chen J, Xu R, Hunt GC, Krinsky ML, Savides TJ. Influence of the number of malignant regional lymph nodes detected by endoscopic ultrasonography on survival stratification in esophageal adenocarcinoma. Clin Gastroenterol Hepatol 2006; 4: 573–9
  • Eloubeidi MA, Wallace MB, Hoffman BJ, Leveen MB, Van Velse A, Hawes RH, , et al Predictors of survival for esophageal cancer patients with and without celiac axis lymphadenopathy: impact of staging endosonography. Ann Thorac Surg 2001;72:212–9; discussion 219–20.
  • Marsman WA, van Wissen M, Bergman JJ, van Lanschot JJ, Obertop H, Tytgat GN, et al. Outcome of patients with esophageal carcinoma and suspicious celiac lymph nodes as determined by endoscopic ultrasonography. Endoscopy 2004; 36: 961–5
  • Tio TL, Tytgat GN. Endoscopic ultrasonography in analysing peri-intestinal lymph node abnormality. Preliminary results of studies in vitro and in vivo. Scand J Gastroenterol 1986; 123(Suppl)158–63
  • Murata Y, Muroi M, Yoshida M, Ide H, Hanyu F. Endoscopic ultrasonography in the diagnosis of esophageal carcinoma. Surg Endosc 1987; 1: 11–6
  • Tio TL, Cohen P, Coene PP, Udding J, den Hartog Jager FC, Tytgat GN. Endosonography and computed tomography of esophageal carcinoma. Preoperative classification compared to the new 1987 TNM system. Gastroenterology 1989; 96: 1478–86
  • Grimm H, Hamper K, Binmoeller KF, Soehendra N. Enlarged lymph nodes: malignant or not?. Endoscopy ;24 Suppl 1992; 1: 320–3
  • Catalano MF, Sivak MV, Jr, Rice T, Gragg LA, Van Dam J. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc 1994; 40: 442–6
  • Bhutani MS, Hawes RH, Hoffman BJ. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc 1997; 45: 474–9
  • Giovannini M, Seitz JF, Monges G, Perrier H, Rabbia I. Fine-needle aspiration cytology guided by endoscopic ultrasonography: results in 141 patients. Endoscopy 1995; 27: 171–7
  • Wiersema MJ, Vilmann P, Giovannini M, Chang KJ, Wiersema LM. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 1997; 112: 1087–95
  • Williams DB, Sahai AV, Aabakken L, Penman ID, van Velse A, Webb J, et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut 1999; 44: 720–6
  • Chang KJ, Soetikno RM, Bastas D, Tu C, Nguyen PT. Impact of endoscopic ultrasound combined with fine-needle aspiration biopsy in the management of esophageal cancer. Endoscopy 2003; 35: 962–6
  • Vazquez-Sequeiros E, Wiersema MJ, Clain JE, Norton ID, Levy MJ, Romero Y, et al. Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology 2003; 125: 1626–35
  • Catalano MF, Alcocer E, Chak A, Nguyen CC, Raijman I, Geenen JE, et al. Evaluation of metastatic celiac axis lymph nodes in patients with esophageal carcinoma: accuracy of EUS. Gastrointest Endosc 1999; 50: 352–6
  • Eloubeidi MA, Wallace MB, Reed CE, Hadzijahic N, Lewin DN, Van Velse A, et al. The utility of EUS and EUS-guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer: a single-center experience. Gastrointest Endosc 2001; 54: 714–9
  • Reed CE, Mishra G, Sahai AV, Hoffman BJ, Hawes RH. Esophageal cancer staging: improved accuracy by endoscopic ultrasound of celiac lymph nodes. Ann Thorac Surg 1999;67:319–21; discussion 322.
  • Parmar KS, Zwischenberger JB, Reeves AL, Waxman I. Clinical impact of endoscopic ultrasound-guided fine needle aspiration of celiac axis lymph nodes (M1a disease) in esophageal cancer. Ann Thorac Surg 2002;73:916–20; discussion 920–1.
  • Giovannini M, Monges G, Seitz JF, Moutardier V, Bernardini D, Thomas P, et al. Distant lymph node metastases in esophageal cancer: impact of endoscopic ultrasound-guided biopsy. Endoscopy 1999; 31: 536–40
  • Vazquez-Sequeiros E, Levy MJ, Clain JE, Schwartz DA, Harewood GC, Salomao D, et al. Routine vs. selective EUS-guided FNA approach for preoperative nodal staging of esophageal carcinoma. Gastrointest Endosc 2006; 63: 204–11
  • Wiersema MJ, Hassig WM, Hawes RH, Wonn MJ. Mediastinal lymph node detection with endosonography. Gastrointest Endosc 1993; 39: 788–93
  • Sharma D, Thakur A, Toppo S, Chandrakar SK. Lymph node counts in Indians in relation to lymphadenectomy for carcinoma of the oesophagus and stomach. Asian J Surg 2005; 28: 116–20
  • Quint LE, Hepburn LM, Francis IR, Whyte RI, Orringer MB. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer 1995; 76: 1120–5
  • Loren DE, Seghal CM, Ginsberg GG, Kochman ML. Computer-assisted analysis of lymph nodes detected by EUS in patients with esophageal carcinoma. Gastrointest Endosc 2002; 56: 742–6
  • Sakamoto F, Natsugoe S, Yoshinaka H, Shimada M, Owaki T, Nakano S, et al. Endosonographic detection of mediastinal lymph node metastasis in superficial carcinoma of the esophagus: assessment by type classification and histogram. J Gastroenterol 2004; 39: 7–13
  • Saftoiu A, Vilmann P, Ciurea T, Popescu GL, Iordache A, Hassan H, et al. Dynamic analysis of EUS used for the differentiation of benign and malignant lymph nodes. Gastrointest Endosc 2007; 66: 291–300
  • Giovannini M, Hookey LC, Bories E, Pesenti C, Monges G, Delpero JR. Endoscopic ultrasound elastography: the first step towards virtual biopsy? Preliminary results in 49 patients. Endoscopy 2006; 38: 344–8
  • Bollschweiler E, Baldus SE, Schroder W, Prenzel K, Gutschow C, Schneider PM, et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 2006; 38: 149–56
  • Vieth M, Rosch T. Endoscopic mucosal resection and the risk of lymph-node metastases: indications revisited?. Endoscopy 2006; 38: 175–9
  • Altorki NK, Sunagawa M, Little AG, Skinner DB. High-grade dysplasia in the columnar-lined esophagus. Am J Surg 1991;161:97–9; discussion 99–100.
  • Ferguson MK, Naunheim KS. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg 1997; 114: 824–9
  • Falk GW, Catalano MF, Sivak MV, Jr, Rice TW, Van Dam J. Endosonography in the evaluation of patients with Barrett's esophagus and high-grade dysplasia. Gastrointest Endosc 1994; 40: 207–12
  • Natsugoe S, Yoshinaka H, Morinaga T, Shimada M, Baba M, Fukumoto T, et al. Ultrasonographic detection of lymph-node metastases in superficial carcinoma of the esophagus. Endoscopy 1996; 28: 674–9
  • Yanai H, Yoshida T, Harada T, Matsumoto Y, Nishiaki M, Shigemitsu T, et al. Endoscopic ultrasonography of superficial esophageal cancers using a thin ultrasound probe system equipped with switchable radial and linear scanning modes. Gastrointest Endosc 1996; 44: 578–82
  • Hasegawa N, Niwa Y, Arisawa T, Hase S, Goto H, Hayakawa T. Preoperative staging of superficial esophageal carcinoma: comparison of an ultrasound probe and standard endoscopic ultrasonography. Gastrointest Endosc 1996; 44: 388–93
  • Murata Y, Suzuki S, Ohta M, Mitsunaga A, Hayashi K, Yoshida K, et al. Small ultrasonic probes for determination of the depth of superficial esophageal cancer. Gastrointest Endosc 1996; 44: 23–8
  • Fukuda M, Hirata K, Natori H. Endoscopic ultrasonography of the esophagus. World J Surg 2000; 24: 216–26
  • Scotiniotis IA, Kochman ML, Lewis JD, Furth EE, Rosato EF, Ginsberg GG. Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma. Gastrointest Endosc 2001; 54: 689–96
  • Vazquez-Sequeiros E, Wiersema MJ. High-frequency US catheter-based staging of early esophageal tumors. Gastrointest Endosc 2002; 55: 95–9
  • Yanai H, Harada T, Okamoto T, Hirano A, Takeo N, Yoshida T, et al. Prognostic value and interobserver agreement of endoscopic ultrasonography for superficial squamous cell carcinoma of the esophagus: a prospective study. Int J Gastrointest Cancer 2003; 34: 1–8
  • Buskens CJ, Westerterp M, Lagarde SM, Bergman JJ, ten Kate FJ, van Lanschot JJ. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc 2004; 60: 703–10
  • May A, Gunter E, Roth F, Gossner L, Stolte M, Vieth M, et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 2004; 53: 634–40
  • Larghi A, Lightdale CJ, Memeo L, Bhagat G, Okpara N, Rotterdam H. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Gastrointest Endosc 2005; 62: 16–23
  • Shimoyama S, Imamura K, Takeshita Y, Tatsutomi Y, Yoshikawa A, Fujishiro M, et al. The useful combination of a higher frequency miniprobe and endoscopic submucosal dissection for the treatment of T1 esophageal cancer. Surg Endosc 2006; 20: 434–8
  • Waxman I, Raju GS, Critchlow J, Antonioli DA, Spechler SJ. High-frequency probe ultrasonography has limited accuracy for detecting invasive adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: a case series. Am J Gastroenterol 2006; 101: 1773–9
  • Pech O, May A, Gunter E, Gossner L, Ell C. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus. Am J Gastroenterol 2006; 101: 2223–9
  • Shami VM, Villaverde A, Stearns L, Chi KD, Kinney TP, Rogers GB, et al. Clinical impact of conventional endosonography and endoscopic ultrasound-guided fine-needle aspiration in the assessment of patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma who have been referred for endoscopic ablation therapy. Endoscopy 2006; 38: 157–61
  • Chemaly M, Scalone O, Durivage G, Napoleon B, Pujol B, Lefort C, et al. Miniprobe EUS in the pretherapeutic assessment of early esophageal neoplasia. Endoscopy 2008; 40: 2–6
  • Rampado S, Bocus P, Battaglia G, Ruol A, Portale G, Ancona E. Endoscopic ultrasound: accuracy in staging superficial carcinomas of the esophagus. Ann Thorac Surg 2008; 85: 251–6
  • Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462–7
  • Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002;359:1727–33.
  • Rice TW, Boyce GA, Sivak MV, Adelstein DJ, Kirby TJ. Esophageal carcinoma: esophageal ultrasound assessment of preoperative chemotherapy. Ann Thorac Surg 1992; 53: 972–7
  • Hordijk ML, Kok TC, Wilson JH, Mulder AH. Assessment of response of esophageal carcinoma to induction chemotherapy. Endoscopy 1993; 25: 592–6
  • Roubein LD, DuBrow R, David C, Lynch P, Fornage B, Ajani J, et al. Endoscopic ultrasonography in the quantitative assessment of response to chemotherapy in patients with adenocarcinoma of the esophagus and esophagogastric junction. Endoscopy 1993; 25: 587–91
  • Dittler HJ, Fink U, Siewert GR. Response to chemotherapy in esophageal cancer. Endoscopy 1994; 26: 769–71
  • Giovannini M, Seitz JF, Thomas P, Hannoun-Levy JM, Perrier H, Resbeut M, et al. Endoscopic ultrasonography for assessment of the response to combined radiation therapy and chemotherapy in patients with esophageal cancer. Endoscopy 1997; 29: 4–9
  • Isenberg G, Chak A, Canto MI, Levitan N, Clayman J, Pollack BJ, et al. Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation. Gastrointest Endosc 1998; 48: 158–63
  • Laterza E, de Manzoni G, Guglielmi A, Rodella L, Tedesco P, Cordiano C. Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy. Ann Thorac Surg 1999; 67: 1466–9
  • Bowrey DJ, Clark GW, Roberts SA, Hawthorne AB, Maughan TS, Williams GT, et al. Serial endoscopic ultrasound in the assessment of response to chemoradiotherapy for carcinoma of the esophagus. J Gastrointest Surg 1999; 3: 462–7
  • Zuccaro G, Jr, Rice TW, Goldblum J, Medendorp SV, Becker M, Pimentel R, et al. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol 1999; 94: 906–12
  • Beseth BD, Bedford R, Isacoff WH, Holmes EC, Cameron RB. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am Surg 2000; 66: 827–31
  • Willis J, Cooper GS, Isenberg G, Sivak MV, Jr, Levitan N, Clayman J, et al. Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma. Gastrointest Endosc 2002; 55: 655–61
  • Kroep JR, Van Groeningen CJ, Cuesta MA, Craanen ME, Hoekstra OS, Comans EF, et al. Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods. Mol Imaging Biol 2003; 5: 337–46
  • Kalha I, Kaw M, Fukami N, Patel M, Singh S, Gagneja H, et al. The accuracy of endoscopic ultrasound for restaging esophageal carcinoma after chemoradiation therapy. Cancer 2004; 101: 940–7
  • Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, et al. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol 2004; 99: 1258–66
  • Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA, Eloubeidi MA. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg 2005; 129: 1232–41
  • Ribeiro A, Franceschi D, Parra J, Livingstone A, Lima M, Hamilton-Nelson K, et al. Endoscopic ultrasound restaging after neoadjuvant chemotherapy in esophageal cancer. Am J Gastroenterol 2006; 101: 1216–21
  • Mesenas S, Vu C, McStay M, Forshaw M, Doig L, Mason R, et al. A large series, resection controlled study to assess the value of radial EUS in re-staging gastro-esophageal cancer following neo-adjuvant chemotherapy. Dis Esophagus 2008; 21: 37–42
  • Hirata N, Kawamoto K, Ueyama T, Masuda K, Utsunomiya T, Kuwano H. Using endosonography to assess the effects of neoadjuvant therapy in patients with advanced esophageal cancer. AJR Am J Roentgenol 1997; 169: 485–91
  • Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, , et al Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 2004;78:1152–60; discussion 1152–60.
  • Chak A, Canto MI, Cooper GS, Isenberg G, Willis J, Levitan N, et al. Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients. Cancer 2000; 88: 1788–95
  • Japanese Society for Esophageal Diseases Guidelines for the clinical and pathologic studies on carcinoma of the esophagus. Jpn J Surg 1976;1976:47–8.
  • Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994; 73: 2680–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.